Merck & Company, Inc. News Headlines

MRK 
$57.63
*  
0.83
1.46%
Get MRK Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Join With Merck For The Long Haul
8/29/2013 3:30:00 PM - Seeking Alpha


AstraZeneca Goes Back To The M&A Well Yet Again
8/26/2013 2:37:00 PM - Investopedia


What Does The FDA's Breakthrough Designation Mean For Investors?
8/26/2013 12:45:00 PM - Seeking Alpha


2 Pharma Stocks With More Than 25% YTD Returns To Consider
8/23/2013 3:46:00 PM - Seeking Alpha


Codexis Continues To Struggle With Little Relief In Sight
8/22/2013 10:14:00 AM - Seeking Alpha


Sanofi 17.7% July/August Upside Again Led Healthcare Dogs
8/22/2013 8:57:00 AM - Seeking Alpha


A Call For Merck To Cut R&D
8/21/2013 2:03:00 PM - Seeking Alpha


MannKind's Phase III Diabetes Drug Results Should Continue Its Upward Trend
8/20/2013 9:26:00 AM - Seeking Alpha


Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
8/12/2013 8:28:00 AM - Seeking Alpha


GTx Inc.: Reader Queries And A Few Random Thoughts
8/11/2013 9:13:00 PM - Seeking Alpha


Depomed: A Profit In Q2 And Stock Is Still Cheap Next To Comps
8/9/2013 3:34:00 PM - Seeking Alpha


Wedbush Expert Declares Money For Biotech Is Still Out There
8/9/2013 11:47:00 AM - Seeking Alpha


Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
8/5/2013 6:34:00 PM - Seeking Alpha


Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
8/5/2013 4:29:00 PM - Seeking Alpha


Why Is BioCryst Pharmaceuticals At 52 Week High Levels?
8/4/2013 12:20:00 PM - Seeking Alpha


New York Post Rumors, The Dark Side And The FOMC
8/2/2013 8:05:00 PM - Seeking Alpha


5 Bullet-Proof Dividend Growers Paying Almost 5% - The Sequel
8/1/2013 7:36:00 PM - Seeking Alpha


Better Margins Can't Hide Merck's Growth Challenges
7/30/2013 1:00:00 PM - Investopedia


Inovio May Prove To Be Merck's Solution
7/30/2013 8:36:00 AM - Seeking Alpha


Merck & Co. Inc. (MRK) Management Discusses Q2 2013 Results (Webcast)
7/30/2013 8:01:00 AM - Seeking Alpha


Merck, Pfizer, Amgen Earnings Previews: Fully Valued, Capital-Allocation Stories
7/29/2013 1:34:00 PM - Seeking Alpha


Caterpillar Tops Dow Dogs With 13.7% July Price Upside
7/26/2013 3:28:00 PM - Seeking Alpha


Expecting Positive Phase III Results For GTx's Cancer Muscle-Wasting Drug
7/26/2013 12:12:00 PM - Seeking Alpha


Meet High Risk And High Reward, Biotech's Profit Partners: Bert Hazlett
7/26/2013 11:03:00 AM - Seeking Alpha


Merck Needs Acquisitions: Here's The List
7/23/2013 7:26:00 AM - Seeking Alpha